MOS
22
2
GME
59
-6
XYL
43
-4
HIG
72
-2
CINF
48
-2
WEC
45
9
KR
50
10
SIG
47
-3
JPM
60
-2
PRU
50
2
DG
32
-2
HAS
49
3
SWN
30
-12
FOX
30
2
VRSK
89
2
VZ
25
-2
ADT
55
25
NFLX
69
5
NDAQ
48
3
PDCO
57
2
MOS
22
2
GME
59
-6
XYL
43
-4
HIG
72
-2
CINF
48
-2
WEC
45
9
KR
50
10
SIG
47
-3
JPM
60
-2
PRU
50
2
DG
32
-2
HAS
49
3
SWN
30
-12
FOX
30
2
VRSK
89
2
VZ
25
-2
ADT
55
25
NFLX
69
5
NDAQ
48
3
PDCO
57
2
Financhill
Back

Accolade Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
53

ACCD
Accolade

Last Price:
6.13
Seasonality Move:
31.33%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.45
Seasonality Move:
3.65%
Buy
53
Accolade (ACCD) is a Buy

Is Accolade a Buy, Sell or Hold?

  • The current Accolade [ACCD] share price is $6.15. The Score for ACCD is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • ACCD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACCD Stock Price Chart

What is Accolade's stock price today?

  • The Accolade share price today is $6.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACCD is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

ACCD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 34.23 Sell
Chaikin Money Flow: 526912 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.35 - 7.35) Sell
Bollinger Bands (100): (7.08 - 11.02) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

ACCD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.25 Sell
20-day SMA: 6.7 Sell
50-day SMA: 7.48 Sell
200-day SMA: 9.47 Sell
8-day EMA: 6.27 Sell
20-day EMA: 6.64 Sell
50-day EMA: 7.47 Sell
200-day EMA: 9.5 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Accolade Earnings Growth & ACCD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.09 per share, an increase this year of $0.82 per share, and an increase next year of $0.14 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Accolade Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):